I.G. Investment Management’s Regeneron Pharmaceuticals REGN Stock Holding History

I.G. Investment Management’s Portfolio REGN Stock Details REGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-3,600	Closed	-$1.4M	–	404
2017 Q1	$1.4M	Sell	3,600 -2,000	-36%	-$741K	0.01%	296
2016 Q4	$2.06M	Buy	5,600 +4,752	+560%	+$1.81M	0.01%	269
2016 Q3	$341K	Hold	848	–	–	﹤0.01%	796
2016 Q2	$296K	Sell	848 -19,276	-96%	-$7.42M	﹤0.01%	806
2016 Q1	$7.25M	Buy	20,124 +34	+0.2%	+$14K	0.03%	305
2015 Q4	$10.9M	Buy	20,090 +264	+1%	+$143K	0.05%	218
2015 Q3	$9.22M	Sell	19,826 -9,676	-33%	-$5.2M	0.04%	237
2015 Q2	$15.1M	Sell	29,502 -144	-0.5%	-$70.3K	0.06%	177
2015 Q1	$13.4M	Buy	29,646 +32	+0.1%	+$13.6K	0.05%	202
2014 Q4	$12.1M	Buy	29,614 +9,714	+49%	+$3.82M	0.04%	204
2014 Q3	$7.17M	Buy	+19,900	New	+$6.67M	0.03%	282

Other funds holding REGN

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Polen Capital Management Boca Raton, Florida $14.5B AUM 5.7% 1-Year Est. Return

I.G. Investment Management's REGN Position: Q2 2017 in Review

I.G. Investment Management sold out of Regeneron Pharmaceuticals (REGN) in Q2 2017, closing a stake of 3,600 shares — an estimated $1.4M sold.

I.G. Investment Management first reported a position in REGN in Q3 2014 and held it in 11 quarters. The position peaked at $15.1M in Q2 2015. 603 funds tracked by Wall St. Rank hold REGN as of Q2 2017.

I.G. Investment Management reported no remaining Regeneron Pharmaceuticals position as of Q2 2017 after selling out during the quarter.
I.G. Investment Management sold 3,600 Regeneron Pharmaceuticals shares in Q2 2017, an estimated $1.4M.
I.G. Investment Management first reported a position in Regeneron Pharmaceuticals in Q3 2014 and held it in 11 quarters.
I.G. Investment Management's Regeneron Pharmaceuticals position peaked at $15.1M in Q2 2015.
603 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2017.

Based on I.G. Investment Management's 13F filing for Q2 2017, filed 14 Aug 2017.